Published on
December 3, 2025
- 06:00 GMT
Althera Laboratories and Tabuk Pharmaceuticals Announce Strategic Partnership for Advanced T2D Therapy in MENA
Partnership leverages Tabuk’s extensive regional leadership to broaden access to Althera’s innovative Type 2 Diabetes combination therapy DUBLIN, DUBLIN, IRELAND, December 3, 2025 /EINPresswire.com/ -- Althera Laboratories Limited, a global …
Distribution channels:
Chemical Industry, Companies
...
